{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:25:57Z","timestamp":1761895557907},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.acuro.2012.05.007","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T21:11:15Z","timestamp":1346965875000},"page":"330-337","source":"Crossref","is-referenced-by-count":6,"title":["Tratamiento farmacol\u00f3gico de los s\u00edntomas del tracto urinario inferior en el hombre: aplicaci\u00f3n de las recomendaciones en la pr\u00e1ctica cl\u00ednica"],"prefix":"10.1016","volume":"37","author":[{"given":"M.","family":"Esteban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2012.05.007_bib0005","unstructured":"Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. Guidelines on the Treatment of Non-neurogenic Male LUTS 2011. Disponible en: http:\/\/www.uroweb.org\/gls\/pdf\/12_Male_LUTS.pdf"},{"key":"10.1016\/j.acuro.2012.05.007_bib0010","unstructured":"Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. for the European Association of Urology. Guidelines on Conservative treatment of non-neurogenic males LUTS. 2010. Disponible en: http:\/\/www. uroweb.org\/gls\/pdf\/BPH%202010.pdf"},{"key":"10.1016\/j.acuro.2012.05.007_bib0015","unstructured":"NICE. National Institute for Health and Clinical Excellence clinical guideline 97. Lower urinary tract symptoms. The management of lower urinary tract symptoms in men [consultado May 2010]. Disponible en: www.nice.org.uk\/guidance\/CG97\/FullGuidance"},{"key":"10.1016\/j.acuro.2012.05.007_bib0020","unstructured":"McVary KT. Guideline on the Management of BPH: 2010 Update. Presentado en AUA Annual Meeting (2010). Disponible en: http:\/\/www.auanet.org\/content\/guidelines-and-quality-care\/clinical-guidelines.cfm?sub=bph"},{"key":"10.1016\/j.acuro.2012.05.007_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","volume":"29","author":"Abrams","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2012.05.007_bib0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardization of terminology of lower urinary tract function: Report from the standardization sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2012.05.007_bib0035","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2012.05.007_bib0040","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2012.05.007_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.acuro.2012.05.007_bib0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eururo.2009.02.026","article-title":"Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder","volume":"56","author":"Irwin","year":"2009","journal-title":"Eur Urol"},{"issue":"Suppl. 11","key":"10.1016\/j.acuro.2012.05.007_bib0055","first-page":"S580","article-title":"Overactive bladder significantly affects quality of life","volume":"6","author":"Abrams","year":"2000","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.acuro.2012.05.007_bib0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1464-410X.2005.05889.x","article-title":"Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries","volume":"97","author":"Irwin","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2012.05.007_bib0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1524-4733.2004.74008.x","article-title":"The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey","volume":"7","author":"Coyne","year":"2002","journal-title":"Value Health"},{"key":"10.1016\/j.acuro.2012.05.007_bib0070","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1464-410X.2008.07601.x","article-title":"The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study","volume":"101","author":"Coyne","year":"2008","journal-title":"BJU Int"},{"issue":"Suppl. 4","key":"10.1016\/j.acuro.2012.05.007_bib0075","first-page":"S98","article-title":"Impact of overactive bladder on work productivity in the United States: results from EpiLUTS","volume":"15","author":"Sexton","year":"2009","journal-title":"Am J Manag Care"},{"issue":"Suppl. 4","key":"10.1016\/j.acuro.2012.05.007_bib0080","first-page":"S90","article-title":"The total economic burden of overactive bladder in the United States: a disease-specific approach","volume":"15","author":"Onukwugha","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.acuro.2012.05.007_bib0085","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1742-1241.2008.01737.x","article-title":"Diagnosis and treatment of lower urinary tract symptoms suggestive of overactive bladder and bladder outlet obstruction among men in general practice in the UK","volume":"62","author":"Morant","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.acuro.2012.05.007_bib0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1742-1241.2010.02561.x","article-title":"Validation of a 3-item OAB awareness tool","volume":"65","author":"Coyne","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.acuro.2012.05.007_bib0095","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch Intern Med"},{"issue":"Suppl. 4","key":"10.1016\/j.acuro.2012.05.007_bib0100","first-page":"S31","article-title":"Acute urinary retention: risks and management","volume":"7","author":"Roehrborn","year":"2005","journal-title":"Rev Urol"},{"key":"10.1016\/j.acuro.2012.05.007_bib0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis","volume":"54","author":"Chapple","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2012.05.007_bib0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MOU.0b013e3283330862","article-title":"Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia","volume":"20","author":"Chapple","year":"2010","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.acuro.2012.05.007_bib0115","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2012.05.007_bib0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.2006.06574.x","article-title":"The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"99","author":"Blake-James","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2012.05.007_bib0125","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1464-410X.2011.10808.x","article-title":"Diagnosis and medical treatment of lower urinary tract symptoms in adult men: applying specialist guidelines in clinical practice","volume":"110","author":"Oelke","year":"2012","journal-title":"BJU Int"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480612002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480612002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T08:59:11Z","timestamp":1594630751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480612002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0210480612002045"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2012.05.007","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}